DaShenLin Pharmaceutical Group Co., Ltd.
603233
Rank in Stocks
#4889
Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese... Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese company based in Guangzhou. It operates across the pharmaceutical supply chain, engaging in the production, distribution, and direct sale of medicinal products throughout the country.
Share Price
$2.64
Market Cap
$3.01B
Change (1 day)
-4.30%
Change (1 year)
2.39%
Country
CN
Trade DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Category
Healthcare
P/B ratio for DaShenLin Pharmaceutical Group Co., Ltd. (603233)
P/B ratio as of October 2026 TTM: 2.72
According to DaShenLin Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 2.72. At the end of 2023 the company had a P/B ratio of 4.24.
P/B ratio history for DaShenLin Pharmaceutical Group Co., Ltd. from 2012 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 2.72 | 10.08% |
| 2024 | 2.47 | -41.85% |
| 2023 | 4.24 | -29.74% |
| 2022 | 6.04 | -0.41% |
| 2021 | 6.06 | -36.47% |
| 2020 | 9.54 | 43.46% |
| 2019 | 6.65 | 29.48% |
| 2018 | 5.14 | -28.36% |
| 2017 | 7.17 | -26.64% |
| 2016 | 9.77 | -12.83% |
| 2015 | 11.21 | -41.88% |
| 2014 | 19.29 | 5.31% |
| 2013 | 18.32 | -10.07% |
| 2012 | 20.37 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 6.251 | 129.91% |
US
|
|
| 13.2547 | 387.50% |
US
|
|
| 4.208 | 54.77% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 127.39% |
NL
|
